June Sherie Almenoff - 10 Dec 2024 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Issuer symbol
TENX
Transactions as of
10 Dec 2024
Net transactions value
$0
Form type
4
Filing time
12 Dec 2024, 19:49:12 UTC
Previous filing
14 Nov 2024
Next filing
01 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TENX Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 10 Dec 2024 Common Stock 100,000 $5.94 Direct
holding TENX Stock Option (right to buy) 4 10 Dec 2024 Common Stock 4 $3200.00 Direct F1
holding TENX Stock Option (right to buy) 4 10 Dec 2024 Common Stock 4 $992.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were previously reported as covering 6,250 shares at an exercise price of $2.00 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.
F2 These options were previously reported as covering 5,000 shares at an exercise price of $0.62 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.